and transferrin receptor (Tfr) as they occur during biosynthesis were studied in the human hepatoma cell line HepG2, which synthesizes both. Early during biosynthesis the Tfr monomer is converted to a disulfidelinked Tfr dimer. The Tfr monomer is not able to bind Tf, but Tf binding is observed as soon as the covalent Tfr dimer is formed and can take place in the ER. The Tf-Tfr complex is transported through the Golgi reticulum and trans-Golgi reticulum (TGR) and is ultimately delivered to an acidic compartment, where Tf releases its Fe 3÷. We did not observe conversion of Tf to apoTf in the TGR, showing that the part of the TGR passed by secreted Tf has a pH higher than 5.5.
I
NTERACTIONS of ligands with receptors are essential in the communication of cells with their surroundings, and furthermore supply the cell with nutrients. When a cell produces both a soluble polypeptide ligand and its receptor, they usually follow the same biosynthetic route. Examples of receptors and corresponding ligands synthesized by the same cell include the couples IL-2/IL-2 receptor, transferrin/transferrin receptor (Tf/Tfr), 1 apolipoprotein E/LDL (ApoE/LDL) receptor, and transforming growth factor or/ epidermal growth factor receptor (TGFc~/EGFR) (for reviews see references 5, 7, 17, 22, 33) . In principle, the simultaneous production of receptor and ligand can result in their binding in the course of biosynthesis. Its consequences may be several, depending on the type of ligand and receptor. When the ligand is a growth factor, binding of the ligand to its receptor during biosynthesis can result in arrival of the ligand-receptor complex at the cell surface, and may produce a growth stimulus for the cell. This situation constitutes a special case of an autocrine loop: secretion of the otherwise released growth factor is not necessary. Autocrine loops have been postulated to operate for TGF, EGF, and PDGF with their respective receptors in different cell lines, and figure prominently amongst the models explaining tumor growth (8) .
When the ligand supplies a cell with certain nutrients (e.g., Tf, LDL), binding of ligand and receptor during bio- : alAT, alphat-antitrypsin; apoE, apolipoprotein E; apoTf, apotransferrin; ASGR, asialoglycoprotein receptor; dNM, 1-deoxynojirimycin; EGFR, epidermal growth factor receptor; 1D-IEF, one-dimensional isoelectric focussing; NANAse, neuraminidase; PDGF, platelet-derived growth factor; Tf, transferrin; Tfr, transferrin receptor; TGFa, transforming growth factor a; TGR, trans-Golgi reticulum.
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synthesis can likewise result in appearance of the complex at the cell surface followed by its internalization. The ligand will thus be delivered back to the cell from which it originated.
To our knowledge, the interaction of receptors with their soluble polypeptide ligands in the course of biosynthesis has not been documented. We studied the interactions of IT with Tfr during biosynthesis in HepG2 cells, because Tf-Tfr interactions at the cell surface and during recycling have been particularly well defined (1, 7, 14, 17, 35) . When Tfbinds to Tfr at the cell surface, the Tf-Tfr complex is internalized and arrives in an acidic endosomal compartment. There Tf releases its bound Fe 3+, but the resulting apotransferrin (apoTf)-Tfr complex is stable at the resident endosomal pH (pH <5.5). The ApoTf-Tfr complex recycles back to the cell surface where it dissociates, because at neutral pH the apoTf-Tfr complex is not stable, apoTf is released, and Tfr can then start a new cycle (7, 17) .
Ligand-receptor interactions during biosynthesis can be studied if such complexes can be isolated. For Tf-Tfr interactions this can be achieved by coimmunoprecipitation of Tf with Tfr, using an anti-Tfr antibody. We show that when the Tf-Tfr ligand-receptor combination is synthesized by one and the same cell (HepG2), q~f can interact with Tfr during biosynthesis and the Tf-Tfr complex is ultimately delivered to a compartment of acidic pH where Tf releases its Fe 3+. The resulting apoTf-Tfr complex will dissociate at neutral pH.
The trans-Golgi reticulum (TGR) does not constitute the compartment where Tf is converted to apoTf.
A ligand-receptor combination that reaches the cell surface through the biosynthetic route will behave similarly to a receptor occupied by ligand added externally. Figure 1 . Uptake of proteins secreted by HepG2. HepG2 cells (two different clones) were allowed to take up secreted proteins, isolated from 35S-labeled HepG2 cells, for different times indicated in minutes above the gel. Total cell lysates, including bound, radiolabeled proteins, were analyzed on SDS-PAGE. Three major proteins bind to HepG2 cells: apolipoprotein E (ApoE) via the apoB/E receptor, albumin (Alb), and transferrin (Tf) via the transferrin receptor. The identity of the proteins indicated, was established by inununoprecipitation.
NANAse digestion of the radiolabeled secreted proteins produced by HepG2 virtually abolishes apoE uptake but not Tf uptake. Note the steady-state levels of bound Tf from 15 min on, consistent with rapid recycling of Tfr. The position of the markers are indicated.
Materials and Methods

Cells and Cell Culture
The human hepatoma cell line HepG2 (18) was grown in DME supplemented with 10% (vol/vol) FCS. The human erythroleukemia cell line I(562 (20) was grown in RPMI-1640 supplemented with 10% (vol/vol) FCS.
Antibodies
The following antibodies were used. Rabbit anti-human transferrin serum and rabbit anti-human al antitrypsin serum (Central Laboratories of the Red Cross Bloodtransfusion Centre, Amsterdam, The Netherlands), mouse anti-human transferrin receptor monoclonal antibody (66Ig10) (36) .
Gel Electrophoresis
SDS gel electrophoresis (9) and one-dimensional isoelectric focussing (1D-IEF) (24) were performed as described. Gels were fluorographed using DMSO/PPO and exposed on Kodak XAR5 films.
Preparation of tW SIMethionine-labeled HepG2 Supernatant
HepG2 cells were cultured on Ham F-12 medium 20 h before labeling, followed by labeling with [35S]methionine in methionine-free RPMI medium for 6 h. The supernatant was removed and concentrated through a Centricon 30 (Amicon Corp., Danvers, MA), followed by removal of free [3SS]methionine by gel filtration on a PD-10 column in water. The resulting preparations were stored at 4°C.
Neuraminidase treatment of HepG2 supernatants was performed at room temperature using 25 U of neuraminidase (type V; Sigma Chemical Co., St. Louis, MO) per nil.
35
Uptake of[ S]Methionine-labeled Proteins
HepG2 cells were plated in 5-cm petri dishes in DME plus 10% FCS. HepG2 cells were then exposed for 24 h to serum-free DME supplemented with 20 mM Hepes, 10 #M 17-~-estradiol, 30 nM Na-selenite, 40 ng/ml dexamethasone, and 10 v,g/rnl insulin. The cells were washed three times with Hank's medium and exposed to l ml of the above described preparation of radiolabeled HepG2 secretory proteins. Samples (individual dishes) were taken at 0, 15, 30, 60, and 120 min. Medium was removed and the cells were washed three times at 4°C with PBS (Dulbecco). Cells were then lysed in 1 ml NP-40 lysis mix (10 mM Tris-HC1, pH 7.4, 5 mM MgC12, 0.5% (vol/vol) NP-40, and 1 mM PMSF). Debris was removed (5 min, 10,000 g) and the supernatant was lyophilized. The residue was resuspended in 30 #1 H20 and 15 #1 2x SDS sample buffer was added. Samples were boiled and analyzed by SDS-PAGE on a 10% gel.
lmmunoprecipitation of Ligand and Receptor
HepG2 cells were exposed to radiolabeled HepG2 supernatant (containing Tf) for 1 h at 0°C in PBS or DME (which contains Fe 3+ that should allow loading of apoTf and its conversion to Tf). Nonbound material was removed by washing with PBS (three times) at 0°C.
Cells were then lysed at either pH 5.1 (50 mM NaAc pH Immunoprecipitates from cells lysed at pH 5.t were washed in 50 mM NaAc pH 5.1, 5 mM EDTA, 150 mM NaC1, and 0.5% (vol/vol) NP-40. Immunoprecipitates from cells lysed at pH 7.4 were washed in a solution of 50 mM Tris-HCl pH 7.4, 150 mM NaCl, 5 mM EDTA and 0.5% (vol/vol) NP-40 (NET buffer). Immune complexes were resuspended in SDS sample mix, boiled, and analyzed by SDS-PAGE on a 10% gel.
Pulse-Chase Experiments
Pulse-chase experiments were performed as described (25) . Binding of secreted radiolabeled Tfto HepG2 cells during the chase was prevented by inclusion of nonradioactive Tf in the labeling medium to a final concentration of 10 #g/ml. For each chase point, one 5-cm petri dish of semiconfluent HepG2 cells was used. Cells were pulsed with [35S]methionine for the times indicated in the results, and incorporation of label was terminated by addition of nonradioactive methionine to a final concentration of 1 raM. Where indicated, chloroquine (100 #M) was added at the beginning of the chase. Cells were lysed in lysis mix (see above) containing 10 #g of nonradioactive Tf per ml. The immunoprecipitations were performed following a strict timetable, resulting in the final washed immunoprecipitate within 4-5 h after lysis of the cells. However, prolonged incubation times during immunoprecipitation (up to 24 h) did not affect the amount of radiolabeled Tf coprecipitated with Tfr (data not shown). Tf from Tf-Tfr complexes was isolated by boiling the Staphylococcus aureus pellet in 20/zl 2 % (wt/vol) SDS for 5 min. NET buffer (950/A) was added, and the supernatant was precleared twice with normal rabbit serum and Staphylococcus aureus. Tf was then immunoprecipitated using the rabbit anti-human transferrin serum.
Endo H digestions were performed as described (25) . NANAse digestion on immunoprecipitates were performed as described (24) .
Tfr Binding to Immobilized Tf
K562 cells were labeled with [3SS]methionine for 60 min, and used as a source of Tfr. Ceils were lysed using NP-40 lysis mix (pH 7.4). Debris was removed and the lysate was precleared with Sepharose. The lysate was incubated with Tf-Sepharose (prepared by coupling Tf to CNBr-activated Sepharose) at 0°C (overnight) in the presence or absence of 10 t~g/ml competing Tf. After removal of Tf-Sepharose, Tfr was immunoprecipitated from the unbound fraction with the mAb 66Ig10 (36) .
The Tf-Sepharose-bound material was washed three times with NETbuffer (pH 7.4) followed by three washes and a 1-h incubation (4°C) with buffer containing 50 mM NaAc (pH 5.1), 5 mM EDTA, and 150 mM NaC1. The elnted material was collected and Tfr was immunoprecipitated from it using 66Ig10 (36) . The Tf-Sepharose was subsequently washed with NET buffer (pH 7.4) and again Tfr was immunoprecipitated from the eluate. The immunoprecipitates were analyzed by SDS-PAGE under nonreducing conditions.
Conversion of apoTf during Secretion
Two dishes of semiconfluent HepG2 cells were labeled with 125 #Ci [35S]methionine in methionine-free RPMI-1640 medium for 4 h in the absence or presence of chloroquine (100 #M). To assess the possible role of free Fe 3+ in the medium, the identical experiment was performed including 10 t~M NaVO3 in the medium. K562 cells (4 x 107) were washed twice with PBS (0°C). Radiolabeled secretory proteins (containing Tf) obtained from HepG2 cells were added to the K562 cells and incubated for 1 h at 0°C. The K562 cells having bound Tf were washed twice with PBS (0°C), lysed in NP-40 lysis mix (pH 7.4) and Tfr was immunoprecipitated using the mAb 66Ig10 (36) . The unbound Tf was immunoprecipitated from the supernatant with the rabbit anti-human Tf serum.
Results
Secretion and Uptake of Glycoproteins by HepG2
HepG2 cells synthesize and secrete considerable quantities of Tf (18) . As in every rapidly dividing cell line, Tfr is also abundantly expressed. In addition, HepG2 cells are positive for the asialoglycoprotein receptor (ASGR) (4, 10) . Because many proteins are synthesized with N-linked glycans, these proteins should be a ligand for the ASGR during passage through the trans-Golgi apparatus, provided they have a terminal galactose residue (10) . Finally, apoE and the LDL receptor, both synthesized by HepG2 cells (34) , constitute a similar couple of receptor and corresponding ligand (13) .
To establish which of these ligand-receptor interactions can be visualized using metabolically labeled ligands, radiolabeled proteins secreted by HepG2 cells were offered to an unlabeled culture of HepG2 cells. At different time points, samples of these cultures were taken, and analyzed by SDS-PAGE for the proteins retained from the mixture of radioactive proteins offered. Surprisingly, the pattern of polypeptides detected was remarkably simple (Fig. 1) , and could be explained by the presence of Tf, albumin, and apoE, as determined by immunoprecipitation with the relevant antisera (data not shown). Albumin sticks nonspecifically to membranes (28) . Indeed, the extent of albumin binding did not show any systematic variation with time or temperature (data not shown). The kinetics of uptake of Tf and apoE were widely different: a continuous increase in the amount of apoE was observed until 120 min, whereas the uptake of Tf had reached a plateau already after 15 min. These observations are consistent with internalization of apoE via the LDL-receptor (13), and Tf entering the "If cycle (6, 16, 17) . Because of the rapid cycling time of Tfr (8-15 min) (6), a steady-state distribution of radiolabeled Tf over the intraand extracellular compartments is rapidly attained.
Prior exposure of radiolabeled proteins secreted by HepG2 to neuraminidase (NANAse) abolished almost completely uptake of apoE, but not binding of albumin or uptake of Tf. Contrary to expectation, no increase in uptake or binding of major desialylated glycoproteins to ASGR was observed. Whether the two clones of HepG2 cells (obtained from different investigators) both express only low levels of ASGR, or whether the native, NANAse-treated, HepG2 secretory proteins are inferior substrates for the ASGR remains to be established. Efficacy of NANAse treatment was checked by 1D-IEF analysis of Tf and al-antitrypsin (a~-AT) (data not shown), and can also be assessed from the difference in the relative molecular mass for NANAseexposed and control Tf (Fig. 1) . For the remainder, we focussed our attention on the Tf-Tfr couple, because of the high levels expressed by HepG2 and of the availability of reagents recognizing Tf and Tfr.
Removal of sialic acids in no way interfered with uptake of Tf (29) . Moreover, Tf produced by cells in the presence of the mannosidase inhibitors 1-deoxynojirimycin (dMM) or swainsonine (11) was likewise taken up efficiently (data not shown). We conclude that the type of N-linked carbohydrates carried by Tf is not a factor that determines its ability to bind to Tfr. This point is of relevance to our biosynthetic experiments described below.
lmmunoprecipitation of the Tf-Tfr Complex
We established the conditions for the recovery of Tf-Tfr complexes by immunoprecipitation at two different pH values. At neutral pH, only the Tf-Tfr complex is stable, whereas at acidic pH (pH <5) the Tf in the Tf-Tfr complex is converted to apoTf. The apoTf-Tfr complex is stable at acidic pH (7, 17) . In the course of the normal Tf cycle, the Tf-Tfr complex reaches the acidic compartment where Fe 3÷ is released from Tf, resulting in the conversion of Tf to apo'lY. As long as the receptor-ligand complex is in acompartment of low pH it is stable: upon return to the cell surface, and thus exposure to neutral pH, apoqY dissociates from Tfr (7, 17) .
HepG2 cells were exposed to 35S-labeled Tf-containing protein mixture (labeled HepG2 supernatant) in PBS (containing no Fe 3÷) or DME (containing Fe3÷). Lysates were prepared at pH 5.1 (where Tf-Tfr is converted to apoTf-Tfr, which is stable at pH 5.1) and at pH 7.4, where only Tf-Tfr is stable. The anti-Tfr antibody 66Ig10 (36) recovers Tfrbound Tf under all experimental conditions tested. Cells maintained in DME invariably give higher recovery of bound Tf, presumably because compared to cells maintained in PBS a smaller proportion of the available Tf is in the apo form, which is unable to bind to Tfr at neutral pH (Fig. 2 A) .
A second round of immunoprecipitation with a polyclonal rabbit anti-human Tf antiserum yields free Tf not in a complex with Tfr. This fraction is greater when lysis is carried out at pH 5.1. The small amount of Tf isolated in the second round of immunoprecipitation at neutral pH could represent "IT bound to molecules other than Tfr or molecules derived from Tf-Tfr complexes disrupted in the course of lysis. Thus, immunoprecipitation at pH 5.1 and at pH 7.4 allows the isolation of ligand-receptor complexes, but the stability of this complex is lower at pH 5.1.
Because lysates of biosynthetically labeled HepG2 contain both Tfr and free "If, precautions must be taken to prevent association of free radiolabeled "If with Tfr. For example, this situation could arise when radiolabeled Tf present in the ER could combine after lysis with Tfr present in a different subcellular compartment. To establish whether this possibility indeed applies, HepG2 cells were pulse labeled for 15 min and chased for 60 min. Immunoprecipitation of Tfr was then carried out in the presence of increasing amounts of competing nonradioactive Tf. The amount of Tf complexed with Tfr was reduced by the inclusion of 10/zg/ml of nonradiolabeled "If, suggesting that some association of receptor and ligand did indeed take place in the lysate (Fig. 2 B) . Raising the concentration of competitor Tf to 100/~g/ml did not further reduce the amount of radiolabeled Tf coimmunoprecipitated. We therefore routinely included 10/~g/ml of competing Tf in our lysis mix in subsequent experiments.
Tf-Tfr Interaction During Biosynthesis
To investigate the interaction of Tf and Tfr in the course of biosynthesis, a series of pulse-chase experiments was carried out (Fig. 3) . Analysis of the immunoprecipitates prepared at pH 7.4 with the anti-Tfr mAb 66Ig10 show rapid transport of Tfr to the trans-Golgi apparatus within 30 min after synthesis, when Tfr becomes resistant to Endo H digestion (Fig. 3 A) . Mature Tfr contains two complex and one high-mannose carbohydrate chain and is therefore always partially susceptible to Endo H treatment (27, 31) . After a 15-rain chase, labeled Tf is coimmunoprecipitated with Tfr. The identity of Tf was proven by dissociation of the anti-Tfr immunoprecipitates, followed by a reprecipitation with the rabbit anti-human "If serum (Fig. 3 B) . In the Tfr-bound Tf fraction, no modification to complex-type N-linked glycans is seen. Analysis of the remaining free Tf present in the lysates shows the appearance in time of Tf of a higher apparent molecular weight, comigrating with Tf recovered from the supernate (Fig. 3 B) . This Tf contains complex-type N-linked glycans only. Note that the amount of Tfr recovered by the mAb 66Ig10 increases towards the later time points of chase. The 66Ig10 antibody was raised against intact cells, and thus presumably dimeric receptor. It is possible that the affinity of 66Ig10 is higher towards the dimeric forms of Tfr.
The immunoprecipitates shown in Fig. 3 , A and B were also analyzed by 1D-IEF to allow the detection of charge modifications of Tf and Tfr. Already after 15 min of chase, Tfr arrives in the trans-Golgi apparatus as monitored by a shift on 1D-IEE due to the addition of (negatively charged) sialic acids (Fig. 3 D) (3, 30) . This modification is essentially complete after 60 min of chase. No such modification is seen for Tf, in agreement with the results of Fig. 3, A and B .
The amount of Tf recovered in the anti-Tfr immunoprecipitates prepared at pH 7.4 increases from 15 until 120 min of chase and subsequently decreases (Fig. 3 A) . This decrease represents loss of Tf from the Tf-Tfr complex due to events described below. Tf bound to Tfr is fully Endo H sensitive (Fig. 3 A) , showing that binding of Tf to Tfr does take place intracellularly. Secreted "IT is Endo H resistant (data not shown) and fully sialylated (Fig. 4 A) . The early binding of Tf (at 15 min of chase) at which no secretion of Tf can be detected (Fig. 3 C) , is further proof that this interaction takes place intracellularly.
The data shown thus far establish that Tf can interact with Tfr during biosynthesis, and that the bound Tf is released subsequently from the Tf-Tfr complex. Where does this dissociation take place? q"f is converted to apoTf in subcellular compartments with a pH lower than 5.5 (7, 17) . In principle, this could occur in (parts of) the TGR; its resident pH is not easily established, but is known to be slightly acidic (2, 14) . If Tf were converted to apoTf in the TGR, then the Tf-Tfr complex likewise will be converted there to apoTf-Tfr, and dissociate upon arrival at the cell surface. Otherwise, it is the Tf-Tfr complex that will arrive at the cell surface, which may then enter the usual Tf cycle. Another explanation is that there is a direct transfer of the Tf-Tfr complex produced biosynthetically to an intracellular compartment that is part of the endocytic pathway. This would also result in delivery of Tf-Tfr complex to an acidic compartment.
To show that an acidic compartment is involved in the dissociation of the biosynthetically labeled Tf-Tfr complex, a pulse-chase experiment was performed in the absence or presence of 100/~M chloroquine, a compound that neutralizes acidic compartments. Cells were lysed in a buffer of pH 7.4 or 5.1. Immunoprecipitation at pH 7.4 results in the recovery of the Tf-Tfr complex only, whereas immunoprecipitation at pH 5.1 results in the conversion of Tf-Tfr and the recovery of all complexes in the apoTf-Tfr form. To improve the signal-to-noise ratio, the isolated Tf-Tfr complex was dissociated by SDS treatment, and "If was immunoprecipitated at pH 7.4. The immunoprecipitates were analyzed by 1D-IEF to visualize the sialylated forms of'If: they represent mature Tf. (Tf contains two complex N-linked glycans [37] with one to four sialic acids; an average of two to three sialic acids per glycan [ Fig. 4 B] .) Neutralization of acidic compartments with chloroquine results in a considerably in the medium because VO3-precipitates Fe 3+ cations. K562 cells were then incubated with the radiolabeled HepG2 supernatant at 0°C for 1 h, the nonbound fraction was removed, and the Tfr-Tf complex was immunoprecipitated from K562 lysates. Tf was immunoprecipitated from the nonbound fraction. Immunoprecipitates were analyzed by SDS-PAGE on 10% gel.
higher recovery of sialylated Tf bound to Tfr when isolated at pH 7.4 (Fig. 4 A, top) . Thus an acidic compartment is involved in the dissociation of Tf from Tfr.
To establish whether the release of Tf from Tfr is preceded by conversion of Tf-Tfr to apoTf-Tfr, we isolated Tfr at pH 5.1. At pH 5.1, the apoTf-Tfr complex is recovered. In contrast to lysis at pH 7.4, lysis at pH 5.1 showed a considerable recovery of sialylated (apo)Tf bound to Tfr (Fig. 4 A, bottom) in comparable quantities for control-and chloroquinetreated cells. The Tf complexed to Tfr and isolated at pH 5.1 but not at pH 7.4 must therefore be apoTf. Tf bound to Tfr in cells exposed to chloroquine will ultimately be released from Tfr by competition with Tf present in the medium (17) .
That conversion of Tf to apoTf does not take place in the secretory pathway (TGR) is based on the following experiment. Binding of Tf to Tfr on the cell surface of intact erythroleukemic K562 cells was used to assess the relative amounts of secreted Tf and apoTf from control and chloroquine-treated cells. Inclusion of choloroquine in the HepG2-labeling medium did not produce a shift in the amount of Tf bound to K562 cells relative to the unbound fraction, which must include apoTf. Inclusion of VO3-in the labeling medium to complex any free Fe 3÷ produced an equivalent result: under the latter conditions, conversion of apoTf to Tf in the medium is precluded (Fig. 4 B) . Had conversion of Tf to apoTf occurred in the secretory pathway in untreated HepG2 cells, no Tfr-bound material would have been expected. However, binding of Tf to the K562 Tfr is observed, and thus we conclude that the TGR is not sufficiently acidic to allow the conversion Tf to apoTf.
Tf-Tfr Interactions Early During Biosynthesis
At early time points of chase, no Tf bound to Tfr is detectable (Figs. 3 A and 5 A) . Because at that time both Tf and most Tfr will be located in the ER (since both are fully Endo H sensitive, Fig. 3 A) , the ER-resident Tfr apparently does not immediately acquire ligand binding capacity, apoTf will not bind to Tfr at neutral pH. After 15 min of chase, Tf binding becomes detectable (Fig. 3 A) . To provide higher temporal resolution in the analysis of events leading to a functional Tfr, HepG2 cells were pulsed for 5 min and chased for the times indicated (Fig. 5 A) . Tfr was analyzed under reducing and nonreducing conditions, the latter allowing the separation of the Tfr monomer and the disulfide linked Tfr homodimer (Fig. 5 A) . "IT binding was detected at 20 min of chase, consistent with the earlier experiment (Fig. 3 A) . The inability to observe interactions of Tfr with Tf during the earliest time points of chase is not a consequence of incomplete N-linked glycan maturation: pulse-chase experiments in the presence or absence of the glucosidase inhibitors (11) dNM or castanospermine revealed no effect on Tf-Tfr interactions (data not shown). The acquisition of "If binding capacity coincided with covalent Tfr dimerization (Fig. 5 A) . Formally, these results do not allow the conclusion that only the disulfide linked Tfr dimer has Tf binding capacity (since radiolabeled Tf can bind to nonradioactive Tfr synthesized during the chase) and, therefore, that the interaction of Tfr with Tf can in fact occur in the ER.
To show that Tf-Tfr interactions can take place in the ER, pulse-labeled HepG2 cells were incubated at 10°C for different periods (Fig. 5 B) . When analyzed under nonreducing conditions, the relative amount of covalently dimerized Tfr was found to increase with time, and, in parallel, the quantity of Tf bound. Even though membrane traffic is arrested at 10°C (note that no glycan modifications are detected for either Tf, Tfr, or t~IAT as deduced from characteristic shift in electrophoretic mobility), covalent Tfr dimerization proceeds at 10°C, and results in the generation of a functional Tfr. We conclude that this Tfr interacts with Tf in the ER.
To show directly that it is the covalent Tfr homodimer that binds Tf, a lysate ofK562 cells (which express large amounts of Tfr) that had been labeled with [3sS]methionine for 60 min, was passed over a Tf-Sepharose column. Tfr was immunoprecipitated from the flow-through of this column and analyzed by nonreducing SDS-PAGE (Fig. 5 C) . The disulfidelinked Tfr homodimer was found to bind to Tf-Sepharose and could or.ly be maintained in the flow-through when the lysate was supplemented by excess, free Tf before passage over Tf-Sepharose. Elution of the Tf-Sepharose-retained material at pH 5.1 did not result in the release of Tfr. At pH 5.1 Tf is converted to apoTf (Fe 3+ is released) but the apoTf-Tfr complex dissociates only when exposed subsequently to neutral pH (7, 17) . Indeed, subsequent exposure of the pH 5.1-treated, bound fraction to pH 7.4 resulted in the release of the disulfide-linked Tfr homodimer. Only a minor fraction of Tfr monomer (or nondisulfide-linked Tfr dimer; these two cannot be distinguished by this criterion) was observed (Fig. 5 C, last lane) .
Discussion
The intracellular interactions of Tf and Tfr synthesized by the human hepatoma cell line HepG2 that we have documented, are depicted schematically in Fig. 6 . Early during biosynthesis the Tfr monomer is converted to a disulfidelinked homodimer (Fig. 5 A) . Covalent dimerization can proceed even at 10°C, albeit slowly, in the ER (Fig. 5 B) . The process of covalent dimerization is largely completed in the ER (Fig. 5, A and B) , but in any case, before arrival in the trans-Golgi apparatus. The formation of this disulfidelinked Tfr may proceed through a nondisulphide-linked Tfr dimer intermediate. The small quantity of Tfr monomer recovered in the experiment shown in Fig. 5 C may in fact derive from such noncovalent dimers. Tfr obtains Tf binding capacity upon dimerization (Fig. 5 C) . The formation of disulfide-linked Tfr dimers is not a prerequisite for transport out of the ER because elimination of the two interchain disulfide bridges by site-directed mutagenesis does not eliminate surface expression or Tf binding properties of Tfr (15) . However, it is possible that Tfr monomers do not leave the ER and Tfr can only do so through the formation of (covalent or noncovalent) dimers (see also reference 12).
The (from IV to VIII) is a possibility not excluded by our experiments. When the Tf-Tfr complex arrives at the cell surface, the Tf-Tfr is internalized and arrives in an (acidic) endosome where Tf releases its Fe 3+ and is converted to apoTf. The apoTf-Tfr complex (stable at acidic pH) recycles back to the cell surface. The apoTf-Tfr complex is unstable at neutral pH, dissociates, and Tfr can bind a new Tf molecule from the surrounding medium and starts a new Tf cycle.
will have obtained in the ER (Fig. 5 B) . Not all Tf binds to Tfr, because Tf is synthesized in molar excess (Fig. 3 B; Tf  contains 9 [21, 37], Tfr contains 11 methionines [23, 32] ). In addition, not all newly synthesized Tf may have bound Fe 3÷ and thus be able to bind to Tfr. The Tf-Tfr complex is transported through the Golgi and the trans-Golgi reticulum (TGR). The pH in the TGR is not sufficiently acidic to convert free Tf to apoTf (Fig. 4 B) and must therefore be higher than pH 5.5 (7, 17) (unless the residence time of Tf in the TGR would be in the order of 1.5 min, the reported half-time of conversion ofTfto apoTf at pH 5 [7] ). Thus, the local conditions are probably compatible with safe passage of Tf-Tfr through the TGR. The experiments in Fig. 4 show that the Tf-Tfr complex is rapidly delivered from the TGR to a compartment of low pH, the target of action of chloroquine. The exact route by which this acidic compartment is reached cannot be established with certainty from our experimental data. It is possible that the Tf-Tfr complex is deposited at the cell surface, from which it is rapidly internalized via the usual endocytic pathway (7, 17) . Alternatively, the Tf-Tfr complex may be delivered directly to the endocytic pathway, and enter the transferrin cycle intracellularly. The kinetics of this process as observed experimentally are too rapid to allow a clear distinction between these two possibilities. For molecules like the mannose-6-phosphate receptor (19) and the major histocompatibility complex class II antigens (26), a direct connection between the TGR and the endocytic route has been shown.
Because Tfr and Tf can interact intracellularly in the course of biosynthesis, this possibility probably also exists for other ligand-receptor combinations synthesized by one and the same cell. In the case of a growth factor and its receptor, such interactions can result in transport to the cell surface and delivery of a growth signal. Whether a growth signal can already be delivered after binding of a growth factor to its receptor in the ER or Golgi is not known. There are several ways by which premature interaction of receptors with their ligands could be prevented. For example, covalent modifications (e.g., disulfide bonding, glycan modifications, phosphorylations) required for full ligand binding potential may take place at a time and location where ligand and receptor are no longer available in the same compartment. The presence of cofactors (e.g., divalent cations, optimal pH for binding) may likewise be a controlling factor.
Coexpression of EGF or TGFct and the EGF-receptor has been observed in a number of tumors and cell lines (8) and a similar situation may apply to other growth factor-growth factor receptor combinations. Their intracellular interactions, which could ultimately contribute to tumor growth, might go along lines parallel to those outlined here for Tf-Tfr.
